http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012054654-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d6c2e03d92a915f759e1bdafc723f36a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b8d329ebc42039eba20b21f1e2155e5d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4249f1dc7cc9f924ebb9314978d98302
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7f362ad5c6099c1167f2b98b0e4cd6b8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c50cdf5672324a2c74141911b29d7658
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b63e00734c7dae2e2dccd070bb2c62cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6062d9771ac6de7592395a9389dfd143
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6e089a1229311ed1e13567f1b6b91b75
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-732
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-77
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30
filingDate 2011-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f36bcecb092bb1f11a8495593538344
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_296fdef5d690b466040b35501ae49173
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3cf1f43d9b0405bf1ee0073332fbb10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03417f3ad218caa6b2d6cf666fdd8f2f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a65496f475f9874f1510defb64e7a184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86ecd73b974c223e1a9e56d6f900b646
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67fedcb7a63483fd431b9bc0b187ea93
publicationDate 2012-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2012054654-A3
titleOfInvention Anti-folate receptor alpha antibody glycoforms
abstract The invention provides anti-FRA antibodies with novel N-linked neutral glycan profiles in that the relative amounts of one or more neutral glycans are increased or decreased compared to anti- FRA antibodies produced under reference cell culture conditions. The invention further provides anti-FRA antibodies with altered binding to FRA, altered antibody-dependent cellular cytotoxicity (ADCC) and/or altered rate and/or efficiency of internalization in a cell expressing FRA. In related aspects, the invention provides cell cultures comprising an anti-FRA antibody of the invention, a cell isolated from such a culture, kits and compositions comprising an anti-FRA antibody of the invention, methods of producing an anti-FRA antibody of the invention and diagnostic and therapeutic uses of an anti-FRA antibody of the invention.
priorityDate 2010-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009324594-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007224188-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009274697-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005232919-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398658
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395976
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395977
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135444779

Total number of triples: 42.